Contact this trialFirst, we need to learn more about you.
Serotonin Modulator
Vortioxetine for Frontotemporal Dementia
Recruiting1 awardPhase 2
Baltimore, Maryland
This trial aims to see if vortioxetine can help improve mood and cognitive symptoms in patients with early-stage behavioral variant Frontotemporal Dementia (bvFTD). Researchers want to find out
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service